Evaluation of Eradication Rates for Macrolide-Based Treatment of Helicobacter pylori Infection in an Era of Increasing Resistance

Abstract

Get full access to this article

View all access options for this article.

References

Malfertheiner

Megraud

O’Morain

. Management of H. pylori infection-the Maastricht IV/Florence consensus report. Gut. 2012;61:646-664. doi:10.1136/gutjnl-2012-302084.

Fischbach

Evans

. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther. 2007;26:343-357. doi:10.1111/j.1365-2036.2007.03386.x.

Segarra-Newnham

Siebert

. Development and outcomes of an ambulatory clinic for Helicobacter pylori treatment. Hosp Pharm. 1998;33:205-209.

Segarra-Newnham

. Treating veterans for Helicobacter pylori infection: retrospective evaluation of long-term outcomes. Hosp Pharm. 2004;39:1165-1168, 1176-1179.

Segarra-Newnham

Coakley

. Salvage options for eradication of Helicobacter pylori during tetracycline backorder. J Pharm Technol. 2012;28:187-192.